Pulmonary hypertension secondary prevention: Difference between revisions
No edit summary |
No edit summary |
||
Line 14: | Line 14: | ||
* Avoid high altitude | * Avoid high altitude | ||
* Supplemental oxygen in order to ensure a target oxygen saturation of 91% in case of exposure to high altitude | * Supplemental oxygen in order to ensure a target oxygen saturation of 91% in case of exposure to high altitude | ||
* Up-to-date immunizations against [[influenza]] and pneumococcal pneumonia | * Up-to-date immunizations against [[influenza]] and [[pneumococcal pneumonia]] | ||
==References== | ==References== |
Revision as of 15:08, 26 March 2018
Pulmonary Hypertension Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pulmonary hypertension secondary prevention On the Web |
American Roentgen Ray Society Images of Pulmonary hypertension secondary prevention |
Risk calculators and risk factors for Pulmonary hypertension secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The recommended measures for the secondary prevention are avoiding pregnancy, rigorous follow up in case of pregnancy, avoid unnecessary surgeries, multidisciplinary care in case of necessary surgery, avoid high altitude, supplemental oxygen in order to ensure a target oxygen saturation of 91% in case of exposure to high altitude, up-to-date immunizations against influenza and pneumococcal pneumonia.
Secondary prevention
Shown below are recommended measures for patients with PAH:[1]
- Avoid pregnancy
- Rigorous follow up in case of pregnancy
- Avoid unnecessary surgeries
- Multidisciplinary care in case of necessary surgery
- Avoid high altitude
- Supplemental oxygen in order to ensure a target oxygen saturation of 91% in case of exposure to high altitude
- Up-to-date immunizations against influenza and pneumococcal pneumonia
References
- ↑ Taichman DB, Ornelas J, Chung L, Klinger J, Lewis S, Mandel J; et al. (2014). "Pharmacological Therapy for Pulmonary Arterial Hypertension in Adults: CHEST Guideline". Chest. doi:10.1378/chest.14-0793. PMID 24937180.